Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

The immune system is comprised of two separate active arms of immunity to provide robust protection against disease. The two separate systems of immunity i | Immunology ...

Scientists from the Garvan Institute of Medical Research have discovered that certain gene changes linked to leukemia may ...

What if your body’s own immune system could be taught to wipe out tumours — and do it so effectively that no further ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.